Funding

• DFG Research Training Grant (GRK2504) „Novel antiviral strategies: from small molecules to immune intervention“.
• Bill & Melinda Gates Foundation, Collaboration on AIDS Vaccine Discovery (CAVD) (OPP1040727) „Induction of affinity-matured HIV Env antibodies in the absence of HIV specific T helper cells".
• EU, European AIDS vaccine initiative 2020 (EAVI 2020).
• DFG UE 45/23-1 „Effector mechanisms of neutralizing and non-neutralizing antibodies against SARS-CoV-2 in a small animal model“.
• DFG UE 45/21-1 „Multifunctional calciumphosphat nanoparticles as novel vaccine platform against HIV-1“.
• DFG UE 45/13-2 „Relevance of Fc effector functions for protection from infection of the first cells in an HIV-1 non-human primate model“.
• BMBF (01KI2043A) „Human antibodies to SARS-Cov2 for the prophylaxis and therapy of COVID-19 (CoVER Ab)“.
• STMWK „Safety and efficacy of vaccination against SARS-CoV-2 (CoVaKo 2021)“.
• STMWK „Prospective Covid-19 cohorte Tirschenreuth (TiKoCo19)“.
• STMWK „Bavarian COVID-19 Research Consortium (FOR-COVID)“.
• BMBF „COVIM – Collaborative Immunity Platform of the NUM (COVIM)“.
• Bayerische Forschungsstiftung „Long-term protection by SARS-CoV-2 antibodies“.
• Bayerische Forschungsstiftung „DeeP‐CMV: Diagnostic, therapy & prevention of CMV‐infection“.

Collaborations

• Prof. Dr. Christian Bogdan, Institute of Microbiology, Uniklinikum Erlangen, Germany
• Prof. Dr. Dennis Burton, The Scripps Research Institute, La Jolla, USA
• Prof. Dr. Oliver Cornely, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Germany
• Prof. Dr. Jutta Eichler, Professor of Medicinal Chemistry, Department of Chemistry and Pharmacy, Faculty of Sciences, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
• Prof. Dr. Matthias Epple, Institute of Inorganic Chemistry, Essen, Germany
• Prof. Dr. Olaf Gefeller, Chair of Medical Biometry and Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, Faculty of Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
• Prof. Dr. Dirk Grimm, Viral Vector Technologies, University Hospital Heidelberg, Germany
• PD Dr. Thomas Grunwald, Preclinical  Validation Unit, Fraunhofer-Institute for Cell Therapy and Immunology, Leipzig, Germany
• Prof Dr. Holger Hackstein,  Department of Transfusion Medicine and Haemostaseology, Uniklinikum Erlangen, Germany
• Prof. Dr. Thomas Harrer, Department of Medicine 3 – Rheumatology and Immunology, Uniklinikum Erlangen, Germany
• Prof. Dr. Iris Heid, Chair of Genetic Epidemiology, University of Regensburg, Germany
• Prof. Dr. Michael Hoelscher, Institute of Infectious Diseases & Tropical Medicine , Ludwig-Maximilians-Universität München, Germany
• Prof. Dr. Hans-Martin Jäck, Division of Immunology, Department of Medicine 3 - Rheumatology and Immunology, Uniklinikum Erlangen, Germany
• Dr. Dietmar Katinger, Polymun Scientific Immunbiologische Forschung GmbH, Bad Klosterneuburg, Austria
• Prof. Dr. Oliver Keppler, Max von Pettenkofer Institute, Ludwig-Maximilians-Universität München, Germany
• Prof. Dr. Florian Klein, Institute of Virology, University Hospital of Cologne, Germany
• Prof. Dr. Thomas Kühlein, Institute of General Practice, Uniklinikum Erlangen, Germany
• Prof. Dr. Bernhard Liebl, Bavarian State Office for Health and Food Safety, Erlangen, Germany
• Prof. Dr. Johannes G. Liese, Department of Pediatrics, Uniklinikum Würzburg, Germany
• Prof. Dr. Anja Lux, Professorship for Integrated Immunology, Chair of Genetics, Faculty of Sciences, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
• Prof. Dr. Stefan Pöhlmann, Infection Biology Unit, German Primate Center (DPZ), Leibniz Institute for Primate Research, Göttingen, Germany
• Prof. Dr. Ulla Protzer, Institute of Virology, Technical University of Munich, Germany
• Prof. Robin Shattock, Department of Infectious Disease, Imperial College London, UK
• Dr. Eileen Socher, Institute for Biochemistry/Institute for Anatomy, Faculty of Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
• Dr. Christiane Stahl-Hennig, Unit of Infection Models at the German Primate Center, Göttingen, Germany
• Prof. Dr. Heinrich Sticht, Professorship for Bioinformatics, Institute for Biochemistry, Faculty of Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
• Prof. Dr. Rüdiger von Kries, Institute of Social Paediatrics and Adolescent Medicine, Ludwig-Maximilians-Universität München, Germany
• Ao.Univ.Prof. Dipl.-Ing. Dr. Karola Vorauer-Uhl, Institute of Bioprocess Science and Engineering, BOKU University, Vienna, Austria
• Prof. Dr. Ralf Wagner, Institute for Microbiology and Hygiene, Universitätsklinikum Regensburg, Germany
• Prof. Dr. Thomas Winkler, Professorship for Genetics, Faculty of Sciences, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
• Prof. Rich Wyatt, The Scripps Research Institute, La Jolla, USA